Live
- Yanamala blames YSRCP policies for collapse of state economy
- Call to inculcate habit of reading books
- 63% parents give milk to their kids to maintain intake of calcium
- Maoist Leader Manjula Surrenders in Warangal, Receives ₹20 Lakh Reward
- Kartika Purnima celebrations fervour marks Telugu States, devotees flock to shiva shrines
- YSRCP alleges meagre fund allocations for Super Six schemes
- Telangana CM Reviews Plans for First Anniversary of State Government
- Vijayawada: Kindness Day celebrated
- Rajamahendravaram: Students advised to set clear goals
- Digital locker facility now available at Namma Metro stations
Omicron BA2 subvariant spreading as EU nations lift Covid curbs: EMA
European Medicines Agency
Cases of Omicron BA2, a Covid-19 subvariant, are rising across the European Union (EU) as member nations were lifting restrictions, the European Medicines Agency (EMA) said.
Brussels: Cases of Omicron BA2, a Covid-19 subvariant, are rising across the European Union (EU) as member nations were lifting restrictions, the European Medicines Agency (EMA) said.
"While many EU countries are lifting restrictions, we notice that the infection rates are increasing again in some member states, partly because of the circulation of Omicron BA2, which seems to be more transmissible than other variants," Xinhua news agency quoted Marco Cavalieri, head of the EMA's strategy on biological health threats and vaccines, as saying to journalists here on Thursday.
What matters the most, he said, is how this increase in cases will stress the healthcare systems.
The EMA called non-vaccinated citizens to get jabbed as soon as possible, emphasizing that there are now five Covid-19 jabs authorised in the EU using different technologies.
"There is currently no evidence that immune response after vaccination is significantly different with Omicron BA2. Vaccines continue to offer high protection against hospitalization and death," he said.
The vaccines that have received conditional marketing authorisation from the EMA are those produced by Pfizer/BioNtech, Moderna, AstraZeneca, Janssen and Novavax.
